Home
Technology
Artificial Intelligence Platform
AI-enabled Site-Specific Integration Cell Line Development Platform AlfaCell
AI-enabled Cell Culture Media Database Platform AlfaMedX
AI-enabled No-screening Cell Culture Media Development Platform AlfaOPA
GBB Store
Druggability Assessment
Cell Line Development
Cell Culture Media Development
Detection and analysis
About GBB
About GBB
History
Board of Directors / Management Team
Company Honors
Partners
News
Company News
Video Center
Upcoming Events
Others
Join Us
中文
English
快速查找
产品服务
产品服务
产品服务
Global
Home
Technology
Artificial Intelligence Platform
AI-enabled Site-Specific Integration Cell Line Development Platform AlfaCell
AI-enabled Cell Culture Media Database Platform AlfaMedX
AI-enabled No-screening Cell Culture Media Development Platform AlfaOPA
GBB Store
Druggability Assessment
Cell Line Development
Cell Culture Media Development
Detection and analysis
About GBB
About GBB
History
Board of Directors / Management Team
Company Honors
Partners
News
Company News
Video Center
Upcoming Events
Others
Join Us
Global
中文
English
Another MNC! Great Bay Bio has added another overseas order
2023-10-18
香港
10月18日
继上周后,大湾生物再与一家跨国企业(MNC)签订培养基开发合作协议,再次展现大湾生物多维度参与国际无血清培养基市场开发和供应的能力。
同时,通过本次合作,该MNC将迅速推进无血清细胞培养基的新原料发现与验证,及培养基工艺的深度优化,将大幅提高生物制品研发和培养基供应效率,提升无血清细胞培养基的未来发展。
Back
Next
Prev
Related News
Great Bay Bio’s 2024 strategy conference was successfully held
Great Bay Bio Won the 2023 Deloitte Rising Star Award
TOP CDMO MNC!Great Bay Bio Add One More Overseas Order
Kingsley Leung, Chairman of Great Bay Bio, Awarded the EY Entrepreneur Of The Year™ 2023 Awards
Great Bay Bio Won the Second Prize in the Shenzhen Innovation Competition
Great Bay Bio leads the Sustainable Development of AI Technology Industrialization by Professional Assessment
Great Bay Bio and MNC Kickstart Strategic Cooperation for AI-Driven Cell Culture Media Development
Great Bay Bio Attend BPI US 2023
Share
Message